|
The top-line for December 2015 quarter inclined by 11% to Rs 713.70 crore. Both the feminine care and health care business posted double digit sales growth in competitive environment behind superior value propositions and the strength of product portfolio. OPM has inclined by 1040 bps to 30.3%. The net profit has increased by 62% to Rs 146.70 crore due to OPM expansion.
Performance for the quarter ended December 2015
The top-line inclined by 11% to Rs 713.70 crore. Both the feminine care and health care business posted double digit sales growth in competitive environment behind superior value propositions and the strength of product portfolio.
OPM has inclined by 1040 bps to 30.3% due to decline in raw material cost by 510 bps to 20.4%, ASP cost by 240 bps to 11.4% and other expenses by 550 bps to 12.7% of adjusted net sales. The operating profit increased by 68% to Rs 216.05 crore.
Other income increased by 21% to Rs 20.59 crore. Interest cost increased by 400% to Rs 2.30 crore. Depreciation has decreased by 11% to Rs 14.19 crore. PBT has increased by 71% to Rs 220.15 crore.
The tax outgo inclined by 92% to Rs 73.45 crore. The effective tax rate inclined from 29.7% to 33.4%. The net profit has increased by 62% to Rs 146.70 crore due to OPM expansion.
Performance for half year ended December 2015
The top-line inclined by 7% to Rs 1312.26 crore. OPM has inclined by 690 bps to 23.8% due to fall in raw material cost and ASP. The operating profit increased by 51% to Rs 312.84 crore.
Other income increased by 10% to Rs 41.80 crore. Interest cost increased by 113% to Rs 3.45 crore. Depreciation was flat at Rs 26.90 crore. PBT has increased by 50% to Rs 324.29 crore.
The tax outgo inclined by 67% to Rs 107.81 crore. The effective tax rate decreased from 29.8% to 33.2%. The net profit has increased by 42% to Rs 216.48 crore.
Promoters holding and valuation
The promoters hold 70.64% stake in the company
The shares of the company are trading around Rs 5856 at BSE.
|